Want to join the conversation?
$KS said its BoD elected Paula Cholmondeley as a director of the company, effective Aug. 11, 2016. Cholmondeley joins the BoD as a Class B director with a term expiring at the annual meeting of stockholders in 2017. $KS increased the number of its directors from 11 to 12.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?